Member Info for Energyshares

Great post PL

They had my innocent post no mention of names just Troll AGM2024 little bit of fun

Removed a few hours later.

So poor this site

All major BP’s are based in USA

Dollar & FDA main reasons

CC knows the USA market and oncology circles so much more opportunity for Avacta to move out of this British cesspit called AIM.

No founder with links to Wetherby holding them back now.

Come on CC get us out of here and LTH’s their losses back.

Everything on the Table

Main trial USA

CEO from USA

Inventor from USA

Eliot Forster took F-Star to USA

New investor fund USA rules

NASDAQ ? USA

New Board members USA ?

Partner or T/O USA firm ?

Something is brewing Comms have gone quiet again.

A.Smith left the company on 30th April.

Has until 29th July to exercise his options, or did he leave on bad terms and has lost the lot.

If a good leaver, the recipient will keep the number of options already vested, and any remaining options will be cancelled. They'll then need to exercise these options into shares within 90 days. Any options not exercised within this timeframe will be cancelled. If a bad leaver, they will lose everything.

https://www.vestd.com/help/what-if-an-employee-leaves#

Apart from CC and the bloke who can’t add up.

Heavily over weight on Diagnostics leadership Team.

THERAPEUTICS LEADERSHIP TEAM

Christina Coughlin

Chief Executive Officer

Tony Gardiner

Chief Financial Officer

Karen Harrison

Chief Operating Officer, Therapeutics

Simon Bennett

Chief Business Officer, Therapeutics

DIAGNOSTICS LEADERSHIP TEAM

Christina Coughlin

Chief Executive Officer

Tony Gardiner

Chief Financial Officer

Craig Slater

Chief Operating Officer, Diagnostics

Matt Johnson

Chief Scientific Officer, Diagnostics

David Wilson

Chief Commercial Officer, Diagnostics

Anne McGurk

Joint Managing Director, Launch Diagnostics

Ian Jones

Joint Managing Director, Launch Diagnostics

BIOGRAPHY

Cathy Fiatte

Directrice Générale, Launch Diagnostics France SAS

Sébastien Goenen

Chief Operating Officer, Coris BioConcept

Agree Soleboy thanks for info.

Avacta board has permanent troll squatters

I don’t have to name them we all know who they are paid disrupters which need to move on.

I use to enjoy popping on the board looking for good research but it’s tiresome now.

Can’t wait for re- rate news to get back in the black and burn the rats.

I’d like to see CC mix it up with RNS news, 2WD cohorts results, director changes price sensitive news release ASAP midday RNS’s.

It’s too easy for City and traders to play with Avacta and Trolls just sit here all day every day disrupting.

Throw some news out at unexpected times don’t let them settle into patterns.

Panic the shorters to move on to other shares…

This is why AVA6000 market share will dramatically increase.

Over 65’s there is no chemo for STS

Dox not given to elderly.

There are no data regarding the management of advanced soft-tissue sarcoma (STS) in elderly patients.

Conclusion

A high proportion of elderly patients with advanced STS were denied chemotherapy. Further efforts are needed to define better the optimal care for fit and unfit elderly patients with STS.

https://www.sciencedirect.com/science/article/pii/S0923753419366438

I noticed in this weeks presentation CC spoke with a lot of excitement about timelines later this year.

I hope at long last LTH’s get a commercial deal either

T/O ,partnership or LD this year.

AS just kept kicking the can down the road,every inflection point promised never came to fruition.But he had a knack of releasing just an enough of a carrot to keep us all invested.

Plenty of cloak and daggers with AS ,which I hope CC changes and starts to communicate more with SH’s.

A few times SH’s let it be known they were not happy but AS was like a bully it’s my ball I can do what I want.

I remember one Interview SH’s demanded with Paul Hill his face was a picture he was fuming and you could tell from his body language he didn’t want to be there.

Now he has gone I’m hoping for a return on my investment from this company after 4 years of just pumping money in.

They have the Holy Grail now it’s time to tell the world.

GLA

When your CEO is an expert oncologist,and you hear the excitement and vision she has for the Pre/Cision Pipeline this is a no brainer.

CBO very busy multiple discussions with BP companies.

Oncologists, Patient Advocates and BP all discussing at AACR

Board strengthening coming sooner hopefully,

Count Dracula Gardiner gone soon and new CFO appointed

Expect an offer for DX very soon, I have a hunch it will be from AS.

His downfall was the DX side of the business and he is probably busy finding investors and an offer at the same price of Heights debt will offered soon so he can go back to his beloved affimers.

Last point will AS still be on the board of Affyxell.

Bella,Ice

If you want to make positive comments put them on a positive thread.

Your keeping a Troll thread at the top of the board

Trolls last few weeks AS hasn’t got a clue mistake after mistake false promises…

Trolls today but AS started company should of kept him…

FFS it’s a company that’s needs Top guidance at this stage in its history.

Bye Oxygen can you take Wynbag with you

Not just PI’s complaining some major II investors know what they have got and know they need a team to extract the best possible outcome from BP.

I expect at least one more to move on.

Now let’s get serious ….. Roll on Avacta

Https://avacta.com/christina-coughlin-md-phd-appointed-chief-executive-officer-of-avacta-group/

Avacta announces that Christina Coughlin, MD, PhD, has been appointed as the new Chief Executive Officer of Avacta. avacta.com/christina-coug… #AVCT

Great post Soleboy

Start of Pre/Cision trial

Smith, Bell ,McClaughlin.

Didn’t see any mistakes through trial everything went well,but it’s now

Smith, Coughlin,Bennett

All this change at the top will affect SP and damage the company?

SP held up when Bell ,McClaughlin were dropped in one liners in RNS’s

Only damage has been car crash placing last few months.

Out the 5 of them only Smith keeps over promising.

Gardiner sitting in the background giving himself shares.

Let’s see what happens next week.

I’m hoping side ways move for Smith and Gardiner moved to Man City accounting team were he would fit in.

Gardiner shocking

With his skills on the abacus,

Man City would be a good career move.